Preparation of magnetic polymer particles with nanoparticles of Fe(0).

Iron nanoparticles (Fe(0)), were encapsulated into polymethyl methacrylate (PMMA), by means of emulsion polymerization techniques in a semicontinuous process. The final average diameter of the composite particle was calculated until three times of average particle of iron particles and were stabilized with a non-ionic surfactant. They were then characterized by scanning electron microscopy and dynamic light scattering. Their magnetic properties were determined by parallel field vibrating-sample magnetometry method. The results indicated that the magnetic properties are a function of polymer concentration in the nanocomposite particle.

Mechanisms compensating Na and water retention induced by long-term reduction of renal perfusion pressure.

Endogenous downregulation of plasma aldosterone (Aldo) concentration, despite increased plasma renin activity (PRA), has been suggested to compensate Na and water retention, which is induced by long-term reduction of renal perfusion pressure (rRPP). To determine whether fixed plasma Aldo concentration would prevent equilibration of 24-h Na and water balances during rRPP, chronically instrumented, freely moving beagle dogs were kept under standardized conditions (daily intake 5.5 mmol Na/kg body wt) and studied for 4 consecutive days under the following conditions: control without rRPP (protocol 1) and rRPP + infusion of Aldo (rRPP + Aldo, protocol 2). Because Aldo administration reduces PRA and, thereby, angiotensin II (ANG II) levels ANG II was additionally infused in protocol 3 (rRPP + ANG II + Aldo). During rRPP + Aldo, 24-h Na balances were never equilibrated. Daily Na retention was approximately 3.5 mmol/kg body wt on day 1 and decreased to approximately 1.6 mmol/kg body wt on day 4; 24-h water balances changed in a similar manner. PRA decreased stepwise. On all rRPP + ANG II + Aldo days, Na and water retentions were more extensive than during rRPP + Aldo. Daily Na retention decreased from approximately 4.4 mmol/kg body wt on day 1 to approximately 3.0 mmol/kg body wt on day 4. Plasma atrial natriuretic peptide increased during both protocols. It is concluded that 1) endogenous downregulation of components of the renin-angiotensin-aldosterone system is a pivotal compensatory mechanism to reduce Na and water retention and 2) natriuretic and diuretic factors seem to be of minor potency, because not even the sum of all could counterbalances the Na- and water-retaining effects of Aldo and ANG II.

Changes of blood pressure, sodium excretion and sodium balance due to variations of the renin-angiotensin-aldosterone system.

UNLABELLED: Studies were performed in partly free moving Beagle dogs, kept under standardized environmental and dietetic conditions (food intake: once daily at 8:30 a.m., 5.5 mmol Na/kg body weight per 24 h). The dogs were chronically instrumented with an inflatable cuff around the aorta above the renal arteries, two aortic catheters above and below the cuff, and a bladder catheter. Three protocols were performed in 7 dogs each: (i) CONTROL: urine collection in 20-min intervals and measurement of Na excretion, continuous registration of mean arterial blood pressure (MABP) and heart rate for 4 consecutive days. (ii) As (i), but additional servocontrolled reduction of the renal perfusion pressure (rRPP) to stimulate renin secretion and the formation of angiotensin II and aldosterone. (iii) As (ii), but additional constant infusion of the angiotensin converting enzyme inhibitor Captopril. Despite rRPP Na is only transiently retained (pressure escape). MABP level is elevated, as long as total-body Na is augmented. In protocol iii no Na retention occurs, indicating that rRPP per se causes no Na retention. MABP level remained unchanged. Independent of the preset MABP level similar diurnal variation in MABP are present in all protocols. During control days major amounts of Na are excreted postprandially. Up to 5:00 p.m. 65% of the daily Na intake is excreted. After disturbance of Na control (protocols ii and iii) the Na excretion is shifted to the evening and night. Probably due to this shift Na retention can be prevented. Furthermore, these results demonstrate that rRPP-induced increases of total body Na and MABP are solely mediated by the activation of the renin-angiotensin-aldosterone system.

Diurnal pattern of sodium excretion in dogs with and without chronically reduced renal perfusion pressure.

In 5 conscious dogs the diurnal patterns of urinary sodium excretion (UNaV) were investigated, initially during 1 control day and, thereafter, during 4 days of servo-controlled reduction of renal perfusion pressure (rRPP). The individual dog's mean arterial blood pressure was reduced to 80% of the blood pressure on the control day. This value was always found to be below the threshold for the pressure-dependent renin release. During the entire study period urine was collected in 4-hour intervals and blood samples were taken every 4 h. The dogs were kept on a standardized high sodium and high water intake and were fed once daily at 8.30 h. On the control day, UNaV, urinary flow rate (UV), fractional lithium excretion (FELi) and fractional sodium excretion (FENa) had similar diurnal patterns. They peaked 4-8 h after food intake and decreased to low values during the night. On day 1 of rRPP, UNaV and FENa were maintained at very low levels in all collection periods, whereas the patterns of UV and FELi were unaltered compared with the patterns on the control day. On days 2-4 of rRPP, a clear-cut maximum in the patterns of UNaV and FENa recurred, comparable with the patterns on the control day. However, compared with the control day this maximum was shifted by 4 h towards the night. In contrast, the patterns of UV and FELi remained unchanged compared with the control day. The results indicate that UNaV has a typical time course in conscious, sodium- and water-replete dogs fed once daily. Endogenous stimulation of sodium reabsorption by means of rRPP results in a characteristic 4-hour shift of UNaV and FENa towards the night during rRPP days 2-4. This delay in UNaV seems to be evoked by processes in the distal tubule.

ACE inhibition prevents Na and water retention and MABP increase during reduction of renal perfusion pressure.

Two groups of six dogs were studied during 4 control days and 4 days of reduced renal perfusion pressure (rRPP) servo controlled at 20% below the individual dog's 24-h mean arterial blood pressure (MABP) during control days, i.e., below the threshold for renin release. On rRPP days, endogenous activation of plasma aldosterone and angiotensin II was inhibited by the angiotensin-converting enzyme inhibitor captopril. The dogs were kept on a high-Na and high-water intake. Unlike studies during rRPP alone, there was no Na and water retention during rRPP+captopril. Glomerular filtration rate dropped by approximately 9%, and MABP remained in the range of control days. Plasma renin activity rose to values 14 times greater than control, whereas plasma aldosterone decreased by approximately 60%. Atrial natriuretic peptide remained in the range of controls. In conclusion, angiotensin-converting enzyme inhibition can prevent the otherwise obligatory Na and water retention and systemic MABP increase during a 20% reduction in renal perfusion pressure. This is achieved most likely via the captopril-induced fall in angiotensin II and plasma aldosterone levels.

Influence of captopril on 24-hour balances and the diurnal patterns of urinary output, blood pressure, aldosterone and atrial natriuretic peptide in conscious dogs.

The diurnal time course of urinary flow rate (UV), urinary sodium (UNaV), and potassium (UKV) excretion, and of hormones such as atrial natriuretic peptide (ANP) and aldosterone, was investigated during 5 days of continuous captopril infusion (15 micrograms.kg body weight-1.min-1) in 4 conscious dogs on a high sodium diet (14.5 mmol Na.kg body weight-1.24 h-1). All food and water was given once daily at 8.30 a.m. On the control day and on days 1, 3, and 5 of captopril infusion, urine was collected by an automated system at 20-min intervals over 24 h, blood was taken every 4 h. Mean arterial blood pressure (MABP) and heart rate were evaluated as 5-min averages. Time courses of UNaV, UV, and UKV were compared with the individual control day without captopril. With captopril, 24-hour balances for Na and H2O were slightly negative, while the K balance was slightly positive for 2-3 days. Thereafter, all 24-hour balances were restored. MABP continued to decrease even after Na and water intake and output had come into balance again. Captopril treatment changed the diurnal excretion pattern for UNaV and UV characteristically. In the postprandial period until 5 p.m., less Na and urine were excreted than on the control day, whereas during the evening and night more Na and urine were excreted. The changes in the excretion pattern persisted for the entire observation period. The results indicate that disturbances in the regulating systems, induced by converting-enzyme blockade, bring about complex reactions of, e.g., MABP, ANP and aldosterone that finally restore Na and water 24-hour input/output balances.

Endogenous variations and sodium intake-dependent components of diurnal sodium excretion patterns in dogs.

1. Automated, sequential, 20 min urine collections were made to provide a record of diurnal variations of urinary sodium excretion (UNaV) in seven dogs, in which the same daily intake of sodium, potassium and water was administered, at first orally (between 08.30 and 08.50 h) on day 1 and then by i.v. infusion at a constant rate on days 2 and 3. This basic protocol was employed for two different levels of sodium intake: normal (NSI; 2.5 mmol (kg body wt)-1 (24 h)-1) and high (HSI; 14.5 mmol (kg body wt)-1 (24 h)-1). 2. The aims were: firstly, to establish the diurnal pattern of UNaV under these circumstances; secondly, to find out whether the quantity of sodium administered influences this diurnal pattern; and thirdly, to distinguish endogenous fluctuations from intake-dependent components in the UNaV excretion patterns. 3. On day 1 (oral intake) all dogs exhibited a similar excretion pattern, which peaked between 13.00 and 15.00 h on both diets and then diminished again over the remainder of the 24 h period. 4. On days 2 and 3 (infusion) UNaV fluctuated within a considerable range. 5. On HSI, the maximal UNaV rates on day 1 were about double those observed on infusion days. On HSI, UNaV during infusion days seems to consist of a constant basal component of about 5-6 mumol (kg body wt)-1 min-1 upon which a fluctuating component is superimposed. The basal component may be a reactive homeostatic response to the high sodium intake, whereas the superimposed fluctuating component may reflect endogenous variations.(ABSTRACT TRUNCATED AT 250 WORDS)

Resetting of 24-h sodium and water balance during 4 days of servo-controlled reduction of renal perfusion pressure.

This study examines whether an increase in renal perfusion pressure (RPP) is necessary to escape endogenously stimulated Na- and water-retaining mechanisms. In seven dogs stimulation was accomplished by a servo-controlled reduction of RPP (rRPP) below the threshold for pressure-dependent renin release for 4 days. Oral intake was standardized. Plasma renin activity (PRA) rose from 2.5 in controls to approximately 5 ng ANG I.ml-1 x h-1 during rRPP days. Plasma aldosterone concentration (PAC) increased by approximately 50% only on day 1 of rRPP but fell at or below control levels thereafter. The PAC-to-PRA ratio decreased during rRPP days. Atrial natriuretic factor (ANF) rose to values three times higher than in controls. Mean systemic blood pressure (MABP) rose from 111 +/- 12 in controls to 142 +/- 14 mmHg on day 4 of rRPP. On day 1 of rRPP 60% of the Na and 24% of the water intake were retained. However, after 2-3 days the input-output balance was restored but on a higher level of total body Na and total body water (new "set point"). Because elevated systemic MABP could not exert direct pressure effects on the kidneys due to servo control of rRPP, there must be other factors, e.g., fall in PAC, increase in ANF, and changes in intrarenal hemodynamics and physical factors that may have contributed to the resetting of input-output balances during rRPP.

Experiencia clínicas con propofol (Driprivan en anestesia intravenosa total (TIVA) / Clinical experience with Propofole (Driprivane) in total intravenous anesthesia (TIVA)

Se estudiaron las alteraciones hemodinámicas y efectos colaterales del PROPOFOL (DIPRIVAN) nuevo anestésico endovenoso en 24 pacientes intervenidos quirurgícamente por diversas patologías en el Hospital Escuela, durante el período comprendido de Noviembre 1988 y Abril 1990. El único efecto hemodinámico de importancia fue la disminución de la presión arterial (rango 20%) que se presentó en todos los pacientes en forma transitoria a los dos minutos de inducción y la apnea de 30 segundos de duración que se presentó como efecto colateral relevante en el 30% de los pacientes. Se concluye que el PROPOFOL es una anestésico de gran utilidad en la anestesia endovenosa total por su estabilidad hemodinámica y relativamente escasos efectos colaterales que sí se presentan son reversibles rápidamente

Experiencia clínica con propofol (Driprivan) en anestesia introvenosa total (Tiva) / Clinical experience with propofole (Driprivane) in total intravenous anesthesia (TIVA)

Se estudiaron las alteraciones hemodinámicas y efectos colaterales del PROPOFOL(DIPRIVAN) nuevo anestésico endovenoso en 24 pacientes intervenidos quirurgícamente por diversas patologías en el Hospital Escuela, durante el período comprendido de noviembre 1988 y abril 1990. El unico efecto hemodinámico de importancia fue la disminución de la presión arterial (rango 20

) que se presentó en todos los pacientes en forma transitoria a los dos minutos de inducción y la apnea de 30 segundos de duración que se presentó como efecto colateral relevante en el 30

de los pacientes.Se concluye que el PROPOFOL es una anestésico de gran utilidad en la anestesia endovenosa total por su estabilidad hemodinámica y relativamente escasos efectos colaterales que sí se presentan son reversibles rápidamente

Elevated serum CK-BB levels in patients with cerebral transtentorial herniation after ischemic stroke.

We examined the time course of CK and its isoenzymes in 15 patients with severe ischemic stroke. Patients with cerebral transtentorial herniation (n = 7) had the highest CK-BB activity during herniation (1.54 +/- 0.6 U/L, mean +/- SD; range: 1.0-2.6 U/L). These values were distinctly above the values of a control group of 20 patients with non-neurological diseases (0.39 +/- 0.2 U/L, mean +/- SD). In patients with smaller lesions without herniation (n = 8) the maximum CK-BB increase was lower (0.56 +/- 0.26 U/L, mean +/- SD).